Contact Us
1 min read

ECFS (EYIM) 2026 Optimization of blocker oligonucleotides as therapies to correct consequences of deep intronic mutations

C. Felgerolle, K. Delétang, I. Pranke, B. Simmoneau, L. Damy, F. Becq, B.Duriez, P. Fanen, I. Sermet, M. Taulan-Cadars – Phymedexp, Inserm U1046 / U1151, CNRS – University of Montpellier,

C. Felgerolle, K. Delétang, I. Pranke, B. Simmoneau, L. Damy, F. Becq, B.Duriez, P. Fanen, I. Sermet, M. Taulan-Cadars – Phymedexp, Inserm U1046 / U1151, CNRS – University of Montpellier, Creteil -France

  • Article details

Published

May 27, 2026

Reading time

1 min read

  • Share article